{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:49:36Z","timestamp":1778694576099,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences, Mashhad, Iran","doi-asserted-by":"publisher","award":["950284"],"award-info":[{"award-number":["950284"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.dsx.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T07:53:25Z","timestamp":1547625205000},"page":"989-994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of diet-induced weight loss on cytokeratin-18 levels in overweight and obese patients with liver fibrosis"],"prefix":"10.1016","volume":"13","author":[{"given":"Mohammad","family":"Safarian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Mohammadpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Shafiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azita","family":"Ganji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anvar","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Nematy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Bahari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.dsx.2019.01.005_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.005_bib2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dsx.2019.01.005_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4254\/wjh.v6.i5.274","article-title":"Gender and racial differences in nonalcoholic fatty liver disease","volume":"6","author":"Pan","year":"2014","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.005_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-10-40","article-title":"Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)","volume":"10","author":"Poynard","year":"2010","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.dsx.2019.01.005_bib5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.005_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.005_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhep.2008.10.014","article-title":"Liver biopsy: the best, not the gold standard","volume":"50","author":"Bedossa","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.dsx.2019.01.005_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.dld.2007.10.019","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Yoneda","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.005_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10620-012-2306-1","article-title":"Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation","volume":"58","author":"Kumar","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.dsx.2019.01.005_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.20051","article-title":"Apoptosis: the nexus of liver injury and fibrosis","volume":"39","author":"Canbay","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.005_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.21223","article-title":"In\u00a0vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease","volume":"44","author":"Wieckowska","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.dsx.2019.01.005_bib12","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study","volume":"50","author":"Feldstein","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.005_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.gastrohep.2017.02.009","article-title":"Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the Chilean population","volume":"40","author":"Arab","year":"2017","journal-title":"Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dsx.2019.01.005_bib14","first-page":"00037","article-title":"Association of serum cytokeratin-18 fragment concentration in patients with different types of nonalcoholic fatty liver disease","volume":"2","author":"Rahman","year":"2015","journal-title":"Gastroenterol Hepatol Open Access"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.005_bib15","doi-asserted-by":"crossref","DOI":"10.5604\/16652681.1171767","article-title":"Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease","volume":"14","author":"Kawanaka","year":"2015","journal-title":"Ann Hepatol: Official Journal of the Mexican Association of Hepatology."},{"issue":"5","key":"10.1016\/j.dsx.2019.01.005_bib16","doi-asserted-by":"crossref","first-page":"e0174394","DOI":"10.1371\/journal.pone.0174394","article-title":"Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.dsx.2019.01.005_bib17","first-page":"25","article-title":"Measurement techniques in anthropometry","volume":"1","author":"Norton","year":"1996","journal-title":"Anthropometrica"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.005_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0399-8320(08)73994-0","article-title":"Transient elastography (fibroscan)","volume":"32","author":"De Ledinghen","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"issue":"11","key":"10.1016\/j.dsx.2019.01.005_bib19","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.005_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/liv.12282","article-title":"Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population","volume":"34","author":"Chon","year":"2014","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.005_bib21","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1478-3231.2012.02781.x","article-title":"Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography","volume":"32","author":"Myers","year":"2012","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.dsx.2019.01.005_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1872-034X.2009.00500.x","article-title":"Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C","volume":"39","author":"Nitta","year":"2009","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.dsx.2019.01.005_bib23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.005_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10803-015-2564-9","article-title":"The gluten-free\/casein-free diet: a double-blind challenge trial in children with autism","volume":"46","author":"Hyman","year":"2016","journal-title":"J\u00a0Autism Dev Disord"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.005_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ajcn\/54.1.182S","article-title":"Nutrition epidemiology: how do we know what they ate?","volume":"54","author":"Barrett-Connor","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.dsx.2019.01.005_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinbiochem.2018.02.006","article-title":"Serum and dietary zinc and copper in Iranian girls","volume":"54","author":"Gonoodi","year":"2008","journal-title":"Clin Biochem"},{"issue":"11","key":"10.1016\/j.dsx.2019.01.005_bib27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.cgh.2008.07.016","article-title":"Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients","volume":"6","author":"Diab","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.dsx.2019.01.005_bib28","doi-asserted-by":"crossref","first-page":"e82092","DOI":"10.1371\/journal.pone.0082092","article-title":"Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.005_bib29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3748\/wjg.v13.i6.837","article-title":"Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis","volume":"13","author":"Yilmaz","year":"2007","journal-title":"World J Gastroenterol: WJG"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.005_bib30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000480142","article-title":"Ability of cytokeratin-18 fragments and FIB-4 index to diagnose overall and mild fibrosis nonalcoholic steatohepatitis in Japanese nonalcoholic fatty liver disease patients","volume":"35","author":"Kobayashi","year":"2017","journal-title":"Dig Dis"},{"key":"10.1016\/j.dsx.2019.01.005_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cca.2014.03.018","article-title":"The cytokeratin-18 fragment level as a biomarker of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"433","author":"Miyasato","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.dsx.2019.01.005_bib32","article-title":"Serum cytokeratin-18 is associated with NOX2-generated oxidative stress in patients with nonalcoholic fatty liver","volume":"2014","author":"Del Ben","year":"2014","journal-title":"Bangladesh Liver J"},{"issue":"6","key":"10.1016\/j.dsx.2019.01.005_bib33","article-title":"Chemerin, retinol binding protein-4, cytokeratin-18 and transgelin-2 presence in sera of patients with non-alcoholic liver fatty disease","volume":"15","author":"Zwolak","year":"2016","journal-title":"Ann Hepatol: Official Journal of the Mexican Association of Hepatology"},{"issue":"1","key":"10.1016\/j.dsx.2019.01.005_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2013.07.042","article-title":"Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease","volume":"60","author":"Cusi","year":"2014","journal-title":"J\u00a0Hepatol"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118305915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118305915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T21:41:30Z","timestamp":1565214090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118305915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1871402118305915"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2019.01.005","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of diet-induced weight loss on cytokeratin-18 levels in overweight and obese patients with liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of Diabetes India.","name":"copyright","label":"Copyright"}]}}